<?xml version="1.0" encoding="UTF-8"?>

<CodeSystem xmlns="http://hl7.org/fhir">
  <id value="kepi-antigen"/>
  <text>
    <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: CodeSystem kepi-antigen</b></p><a name="kepi-antigen"> </a><a name="hckepi-antigen"> </a><p>This  code system <code>https://fhir.slade360.co.ke/fhir/CodeSystem/kepi-antigen</code> defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style="white-space:nowrap">bcg<a name="kepi-antigen-bcg"> </a></td><td>BCG</td><td>Bacille Calmette-Guerin vaccine, given at birth against tuberculosis.</td></tr><tr><td style="white-space:nowrap">bopv<a name="kepi-antigen-bopv"> </a></td><td>Bivalent oral poliovirus vaccine</td><td>Live attenuated oral polio vaccine containing types 1 and 3. Given as a birth dose and at 6, 10 and 14 weeks.</td></tr><tr><td style="white-space:nowrap">ipv<a name="kepi-antigen-ipv"> </a></td><td>Inactivated poliovirus vaccine</td><td>Injectable inactivated polio vaccine, given at 14 weeks alongside the third bivalent oral dose. A distinct product from bOPV despite the register sharing one item code between them.</td></tr><tr><td style="white-space:nowrap">penta<a name="kepi-antigen-penta"> </a></td><td>DTP-HepB-Hib (pentavalent) vaccine</td><td>Combined diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine. Given at 6, 10 and 14 weeks.</td></tr><tr><td style="white-space:nowrap">pcv10<a name="kepi-antigen-pcv10"> </a></td><td>Pneumococcal conjugate vaccine (PCV10)</td><td>Ten-valent pneumococcal conjugate vaccine, given at 6, 10 and 14 weeks.</td></tr><tr><td style="white-space:nowrap">rota<a name="kepi-antigen-rota"> </a></td><td>Rotavirus vaccine</td><td>Oral rotavirus vaccine, given at 6 and 10 weeks.</td></tr><tr><td style="white-space:nowrap">mr<a name="kepi-antigen-mr"> </a></td><td>Measles-rubella vaccine</td><td>Combined measles and rubella vaccine. First dose at 9 months, second between 18 months and 2 years.</td></tr><tr><td style="white-space:nowrap">yf<a name="kepi-antigen-yf"> </a></td><td>Yellow fever vaccine</td><td>Yellow fever vaccine, given at 9 months in yellow-fever-risk counties only, which is why it is excluded from the Fully Immunised Child milestone.</td></tr></table></div>
  </text>
  <url value="https://fhir.slade360.co.ke/fhir/CodeSystem/kepi-antigen"/>
  <version value="0.1.0"/>
  <name value="SGHIKEPIAntigenCodeSystem"/>
  <title value="SGHI KEPI Antigen"/>
  <status value="active"/>
  <date value="2026-09-15T11:40:24+00:00"/>
  <publisher value="Kathurima Kimathi"/>
  <contact>
    <name value="Kathurima Kimathi"/>
    <telecom>
      <system value="url"/>
      <value value="https://www.linkedin.com/in/kathurima-kimathi/"/>
    </telecom>
    <telecom>
      <system value="email"/>
      <value value="kathurimakimathi415@gmail.com"/>
    </telecom>
  </contact>
  <contact>
    <name value="Oscar John"/>
    <telecom>
      <system value="email"/>
      <value value="oscarjohnotieno@gmail.com"/>
      <use value="work"/>
    </telecom>
  </contact>
  <contact>
    <name value="Kennedy Omondi"/>
    <telecom>
      <system value="email"/>
      <value value="kennankole@gmail.com"/>
      <use value="work"/>
    </telecom>
  </contact>
  <description value="Antigens administered under the Kenya Expanded Programme on Immunisation, as recorded on the MOH 510 Immunisation Permanent Register. One concept per antigen: the dose within a series is carried separately on Immunization.protocolApplied.doseNumber, which is what keeps IPV distinct from bivalent OPV and separates the three pentavalent doses. Pending a mapping to CVX or the national antigen list."/>
  <content value="complete"/>
  <count value="8"/>
  <concept>
    <code value="bcg"/>
    <display value="BCG"/>
    <definition value="Bacille Calmette-Guerin vaccine, given at birth against tuberculosis."/>
  </concept>
  <concept>
    <code value="bopv"/>
    <display value="Bivalent oral poliovirus vaccine"/>
    <definition value="Live attenuated oral polio vaccine containing types 1 and 3. Given as a birth dose and at 6, 10 and 14 weeks."/>
  </concept>
  <concept>
    <code value="ipv"/>
    <display value="Inactivated poliovirus vaccine"/>
    <definition value="Injectable inactivated polio vaccine, given at 14 weeks alongside the third bivalent oral dose. A distinct product from bOPV despite the register sharing one item code between them."/>
  </concept>
  <concept>
    <code value="penta"/>
    <display value="DTP-HepB-Hib (pentavalent) vaccine"/>
    <definition value="Combined diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine. Given at 6, 10 and 14 weeks."/>
  </concept>
  <concept>
    <code value="pcv10"/>
    <display value="Pneumococcal conjugate vaccine (PCV10)"/>
    <definition value="Ten-valent pneumococcal conjugate vaccine, given at 6, 10 and 14 weeks."/>
  </concept>
  <concept>
    <code value="rota"/>
    <display value="Rotavirus vaccine"/>
    <definition value="Oral rotavirus vaccine, given at 6 and 10 weeks."/>
  </concept>
  <concept>
    <code value="mr"/>
    <display value="Measles-rubella vaccine"/>
    <definition value="Combined measles and rubella vaccine. First dose at 9 months, second between 18 months and 2 years."/>
  </concept>
  <concept>
    <code value="yf"/>
    <display value="Yellow fever vaccine"/>
    <definition value="Yellow fever vaccine, given at 9 months in yellow-fever-risk counties only, which is why it is excluded from the Fully Immunised Child milestone."/>
  </concept>
</CodeSystem>